2026 NPPES data Rheumatology Physician NPI 1205039997 MD
Verify on CMS →

AMPARO GORDIAN, MD

Rheumatology Physician in BRADENTON, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 250 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.9936/100
▼ 0 pts below national avg 83.1 · [object Object]
Industry payments
$2.9K
142 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AMPARO GORDIAN, MD reported a CMS MIPS final score of 82.9936/100 — below the 83.1 national average — and filed 1,320 Medicare Part D claims in 2023.

82.9936/100
MIPS score · 0 vs avg
1K
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMPARO GORDIAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

83 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

AMPARO GORDIAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AMPARO GORDIAN, MD?

Near national average

NPI registry status

Active

Issued 06/08/2007

NPI 1205039997

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

1,320 36% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

MIPS final score

82.9936/100 0.10639999999999361% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Rheumatology Physician compares to other specialties among Florida providers

Florida providers

Rheumatology Physician share within Florida

1. Rheumatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Rheumatology Physician share within Florida

Medicare quality performance — MIPS

AMPARO GORDIAN, MD's 2023 MIPS final score plotted against the Rheumatology Physician national average

Near national average
MIPS Final Score
82.9936/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Rheumatology Physician) — 82.9936/100 vs national avg 83.1

0%100%National avg83%83%
MIPS final score (Rheumatology Physician) — 82.9936/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMPARO GORDIAN, MD appears in the CMS NPPES registry as a Rheumatology Physician provider holding MD credentials at 4900 MANATEE AVE W STE 201, BRADENTON, FL, 34209, with a listed phone of (941) 746-5200. NPI 1205039997 was issued on 06/08/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GORDIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,320 prescription claims written by this provider, covering 250 Medicare beneficiaries and totaling roughly $475K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.9936/100 for the 2023 performance year (Quality 98.8961, Cost 48.5825), compared with the national average of 83.1.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4900 MANATEE AVE W STE 201
BRADENTON, FL 34209

Provider Details

NPI 1205039997
Specialty Rheumatology Physician
Credentials MD
Gender Female
NPI Issued 06/08/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.9936
Final Score
Avg: 83.1
98.8961
Quality
48.5825
Cost
95
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where AMPARO GORDIAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

WEITZNER YONKER AND KAINE MD PA
SARASOTA, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMPARO GORDIAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.9K

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to AMPARO GORDIAN, MD. To verify AMPARO GORDIAN, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

AMPARO GORDIAN, MD — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 1,320 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,320
Total Claims
$475K
Total Drug Cost
250
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,230
Total Day Supply
64,891
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$444K
Generic Drug Cost
$30K

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.34
Gender Split
78% female / 22% male
Age Distribution
<65: 23, 65-74: 129, 75-84: 82, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AMPARO GORDIAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
334
Hydroxychloroquine Sulfate
228
Methotrexate
Methotrexate Sodium
221
Leflunomide
67
Duloxetine Hcl
45
Gabapentin
44
Methylprednisolone
40
Meloxicam
36
Celecoxib
29
Alendronate Sodium
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How AMPARO GORDIAN, MD fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

AMPARO GORDIAN, MD's 1,320 claims are below the specialty average of 2,054.

Nearby Rheumatology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GORDIAN.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMPARO GORDIAN, MD's specialty?
AMPARO GORDIAN, MD specializes in Rheumatology Physician and practices in BRADENTON, Florida. Credentials: MD.
How much does AMPARO GORDIAN, MD prescribe under Medicare Part D?
In 2023, AMPARO GORDIAN, MD wrote 1,320 Medicare Part D claims totaling $475K in drug costs for 250 beneficiaries.
What is AMPARO GORDIAN, MD's Medicare quality score?
AMPARO GORDIAN, MD has a CMS MIPS Final Score of 82.9936/100 (Quality: 98.8961, Cost: 48.5825). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AMPARO GORDIAN, MD located?
AMPARO GORDIAN, MD is located at 4900 MANATEE AVE W STE 201, BRADENTON, FL, 34209. Phone: (941) 746-5200.
What is AMPARO GORDIAN, MD's NPI number?
AMPARO GORDIAN, MD's National Provider Identifier (NPI) is 1205039997, issued on 06/08/2007.
Does AMPARO GORDIAN, MD prescribe more brand-name or generic drugs?
AMPARO GORDIAN, MD's prescribing is 7% brand-name and 93% generic drugs by claim count, with $444K in brand drug costs.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does AMPARO GORDIAN, MD prescribe most often?
Based on 2023 Medicare Part D data, AMPARO GORDIAN, MD's most frequently prescribed drugs include Prednisone, Hydroxychloroquine Sulfate, Methotrexate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMPARO GORDIAN, MD accept Medicare?
AMPARO GORDIAN, MD appears in CMS Medicare data with 1,320 Part D claims and 250 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMPARO GORDIAN, MD's credentials?
AMPARO GORDIAN, MD's NPI is 1205039997 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology